Engineering a new cancer detection tool

June 8, 2017, Griffith University
cancer
Killer T cells surround a cancer cell. Credit: NIH

Studying the food poisoning bacteria E. coli may have led scientists to discover a new and improved tool to detect cancer.

In a collaborative research project, scientists from Griffith University's Institute for Glycomics, the University of Adelaide and University of Queensland have detailed their findings in a new paper published in Scientific Reports.

Professor Michael Jennings from the Institute for Glycomics said the E. coli produces a toxin which binds to an unusual sugar that is part of carbohydrate structures present on cells (Neu5Gc) which is not usually produced by .

"The structure that the toxin recognises is known to be a tumour antigen, that is, a substance produced by which are recognised markers for detection and diagnosis."

The research team then took the naturally-occurring toxin and engineered it to change the protein make-up so it became entirely specific to detecting only this singular tumour antigen structure.

"The real innovation here is that we have converted something that was discovered in an infectious disease research program into and were able to utilise it as a tool for potentially detecting tumour antigens," Professor Jennings said.

This tumour antigen is made by a wide range of cancers including breast and ovarian cancer.

"There's a saying in science that chance favours the prepared mind and because at the Institute we work with both infectious diseases and cancer research there was a cross fertilization of ideas and opportunity."

"We were very surprised at how well the engineering of this protein worked and we were able to remove the binding characteristics that were useless in a diagnostic sense and re-engineer it to make it totally specific for the antigen target," he said.

The Neu5Gc is expressed at very high levels on cancer cells but not normal so the discovery of Neu5Gc indicates the patient may be suffering cancer.

Humans are unable to make Neu5Gc but is absorbed into the human body through dietary intake of red meat and dairy.

Professor Jennings said more research has to be done but the important thing is this new tool has the potential to detect far more sensitively, a wide range of possible cancers.

Explore further: Tumor-trained T cells go on patrol

More information: Christopher J. Day et al, Structure aided design of a Neu5Gc specific lectin, Scientific Reports (2017). DOI: 10.1038/s41598-017-01522-9

Related Stories

Tumor-trained T cells go on patrol

May 15, 2017
'Tumour-trained' immune cells - which have the potential to kill cancer cells - have been seen moving from one tumour to another for the first time. The new findings, which were uncovered by scientists at Australia's Garvan ...

Tumour protein could hold key to pancreatic cancer survival

February 23, 2017
A diagnosis of pancreatic cancer is often a death sentence because current chemotherapies have little impact on the disease.

Blood test provides clues to bladder cancer patients' prognoses

February 13, 2017
New research indicates that about one-quarter of patients with bladder cancer treated with radical surgery on curative intent have detectable levels of tumour cells circulating in their blood. The presence of circulating ...

Scientists discover how breast cancer cells spread from blood vessels

February 9, 2016
Researchers have identified a protein that controls how breast cancer cells spread around the body, according to a Cancer Research UK-funded study published in Science Signaling today (Tuesday).

Scientists develop exciting new option for targeted cancer therapy

December 8, 2016
Scientists from Trinity College Dublin have uncovered a new class of compounds - glyconaphthalimides - that can be used to target cancer cells with greater specificity than current options allow.

Recommended for you

Targeting molecules called miR-200s and ADAR2 could prevent tumor metastasis in patients with colorectal cancer

April 24, 2018
Colorectal cancer is the third most common cancer worldwide and the third-leading cause of cancer-related deaths. The main cause of death in patients with colorectal cancer is liver metastasis, with nearly 70% of patients ...

Changes in breast tissue increase cancer risk for older women

April 24, 2018
Researchers in Norway, Switzerland, and the United States have identified age-related differences in breast tissue that contribute to older women's increased risk of developing breast cancer. The findings, published April ...

Removing the enablers: Reducing number of tumor-supporting cells to fight neuroblastoma

April 24, 2018
Investigators at the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles provide preclinical evidence that the presence of tumor-associated macrophages—a type of immune cell—can negatively ...

Technology used to map Mars now measuring effect of treatment on tumours

April 24, 2018
A machine learning approach for assessing images of the craters and dunes of Mars, which was developed at The University of Manchester, has now been adapted to help scientists measure the effects of treatments on tumours.

New test could tell doctors whether patients will respond to chemotherapy

April 24, 2018
Less than half the patients diagnosed with cancer respond favorably to chemotherapy, but a new method for testing how patients will respond to various drugs could pave the way for more personalized treatment.

Vitamin A derivative selectively kills liver cancer stem cells

April 23, 2018
Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurrence of hepatocellular carcinoma (HCC), the most common form of liver cancer. Now, in research published in Proceedings ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.